{'52WeekChange': 0.64688206,
 'SandP52WeekChange': 0.0644362,
 'address1': '42505 Tenth Street West',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 65.86,
 'askSize': 800,
 'averageDailyVolume10Day': 174575,
 'averageVolume': 258660,
 'averageVolume10days': 174575,
 'beta': -0.139495,
 'beta3Year': None,
 'bid': 65.8,
 'bidSize': 800,
 'bookValue': 2.619,
 'category': None,
 'circulatingSupply': None,
 'city': 'Lancaster',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 66.115,
 'dayLow': 63.4307,
 'dividendRate': 0.24,
 'dividendYield': 0.0036000002,
 'earningsQuarterlyGrowth': 0.016,
 'enterpriseToEbitda': 79.788,
 'enterpriseToRevenue': 29.065,
 'enterpriseValue': 1164781440,
 'exDividendDate': 1595548800,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 58.544285,
 'fiftyTwoWeekHigh': 70.28,
 'fiftyTwoWeekLow': 26,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': 1.51,
 'floatShares': 12929346,
 'forwardEps': 0.65,
 'forwardPE': 101.169235,
 'fromCurrency': None,
 'fullTimeEmployees': 107,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.2768,
 'heldPercentInstitutions': 0.53396,
 'industry': 'Health Information Services',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1567209600,
 'lastMarket': None,
 'lastSplitDate': 1191283200,
 'lastSplitFactor': '2:1',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/simulations-plus.com',
 'longBusinessSummary': 'Simulations Plus, Inc. develops drug discovery and '
                        'development software for mechanistic modeling and '
                        'simulation, and machine-learning-based prediction of '
                        'properties of molecules from their structure '
                        'worldwide. The company offers GastroPlus, which '
                        'simulates the absorption, pharmacokinetics (PK), '
                        'pharmacodynamics, and drug-drug interactions of '
                        'compounds administered to humans and animals; DDDPlus '
                        'that simulates in vitro laboratory experiments that '
                        'measure the rate of dissolution of the drug and '
                        'additives in a dosage form; and MembranePlus, which '
                        'simulates laboratory experiments. It also provides '
                        'PKPlus, a standalone program that provides the '
                        'functionality needed by pharmaceutical industry '
                        'scientists to perform the analyses and generate the '
                        'outputs needed to satisfy regulatory agency '
                        'requirements for NCA and compartmental PK modelling; '
                        'ADMET Predictor, a chemistry-based computer program '
                        'that takes molecular structures as inputs and '
                        'predicts their properties; and MedChem Designer, a '
                        'molecule drawing program or sketcher. In addition, it '
                        'offers MedChem Studio, a software tool for data '
                        'mining and designing new molecules; KIWI, a '
                        'cloud-based Web application to organize, process, '
                        'maintain, and communicate the volume of data and '
                        'results generated by pharmacologists and scientists '
                        'over the duration of a drug development program; '
                        'DILIsym, a quantitative systems pharmacology '
                        'software; NAFLDsym, a simulation program for '
                        'analyzing nonalcoholic fatty liver disease; and '
                        'RENAsym for investigating and predicting drug-induced '
                        'or acute kidney injury. Further, the company provides '
                        'population modeling and simulation contract research '
                        'services for the pharmaceutical and biotechnology '
                        'industries; and clinical-pharmacology-based '
                        'consulting services in support of regulatory '
                        'submissions. It sells its pharmaceutical/chemistry '
                        'software to pharmaceutical, biotechnology, '
                        'agrochemical, cosmetics, and food companies. The '
                        'company was founded in 1996 and is headquartered in '
                        'Lancaster, California.',
 'longName': 'Simulations Plus, Inc.',
 'market': 'us_market',
 'marketCap': 1171119872,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_366946',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1590883200,
 'navPrice': None,
 'netIncomeToCommon': 9203152,
 'nextFiscalYearEnd': 1630368000,
 'open': 66.06,
 'openInterest': None,
 'payoutRatio': 0.4706,
 'pegRatio': 9.44,
 'phone': '661-723-7723',
 'previousClose': 66.48,
 'priceHint': 2,
 'priceToBook': 25.108822,
 'priceToSalesTrailing12Months': 29.22328,
 'profitMargins': 0.22965,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 66.115,
 'regularMarketDayLow': 63.4307,
 'regularMarketOpen': 66.06,
 'regularMarketPreviousClose': 66.48,
 'regularMarketPrice': 66.06,
 'regularMarketVolume': 158010,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 17809000,
 'sharesPercentSharesOut': 0.098000005,
 'sharesShort': 1742860,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1171165,
 'shortName': 'Simulations Plus, Inc.',
 'shortPercentOfFloat': 0.1375,
 'shortRatio': 7.2,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'SLP',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': 0.24,
 'trailingAnnualDividendYield': 0.003610108,
 'trailingEps': 0.51,
 'trailingPE': 128.94118,
 'twoHundredDayAverage': 41.942158,
 'volume': 158010,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.simulations-plus.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '93534'}